Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

NCT00002449 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Aldesleukin

Sponsor

Chiron Corporation